Global Health
Page 1 • 2 itemsGain critical intelligence on global health trends, pharmaceutical market dynamics, and regulatory shifts impacting drug development and access worldwide.
GHIT Fund Invests $8.5 Million in Malaria and NTD Drug Development with GSK, Eisai Partners
GHIT Fund announces $8.5 million investment across five R&D projects for malaria and neglected tropical disease treatments with major pharma partners.
GHIT Fund Invests $8.5 Million in Malaria and Neglected Tropical Disease Drug Development with GSK, Eisai Partners
GHIT Fund announces $8.5M investment across five R&D projects targeting malaria and neglected tropical diseases with pharmaceutical partners.